Filing Flows › Ultralife (ULBI) › Capital expenditures
Ultralife (ULBI) capital expenditures by quarter
Ultralife's capital expenditures were $453K in Q2 2026 (second quarter 2026), -41% from Q1 2026. Over the last 6 quarters it ranged from $453K (Q2 2026) to $1.1M (Q2 2025).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $453K | -41% | -59% |
| Q1 2026 | $770K | -13% | -14% |
| Q4 2025 | $882K | -11% | — |
| Q3 2025 | $995K | -10% | — |
| Q2 2025 | $1.1M | +23% | — |
| Q1 2025 | $895K | — | — |
Q2 2026 at a glance
Ultralife, Q2 2026: revenue $47.9M (-1% year over year), operating margin 7.2%, net earnings $2.5M, operating cash flow $1.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Ultralife's capital expenditures?
Ultralife's capital expenditures were $453K in Q2 2026 (second quarter 2026), -41% from Q1 2026.
How has Ultralife's capital expenditures changed?
Over the last 6 quarters it ranged from $453K (Q2 2026) to $1.1M (Q2 2025).